메뉴 건너뛰기




Volumn 29, Issue 5, 2018, Pages 1312-1319

Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients

Author keywords

Dendritic cell vaccination; Intratumoral injections; Poly ICLC (Hiltonol); Radiotherapy and abscopal effects

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CARBOXYMETHYLCELLULOSE POLYCYTIDYLIC POLYINOSINIC ACID POLYLYSINE; CYCLOPHOSPHAMIDE; DENDRITIC CELL VACCINE; HILTONOL; INTERLEUKIN 12; INTERLEUKIN 1BETA; MESSENGER RNA; CANCER VACCINE; CARBOXYMETHYLCELLULOSE; CYTOKINE; POLYINOSINIC POLYCYTIDYLIC ACID; POLYLYSINE; TUMOR ANTIGEN;

EID: 85047640614     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdy089     Document Type: Article
Times cited : (105)

References (33)
  • 1
    • 84857793524 scopus 로고    scopus 로고
    • Decisions about dendritic cells: past, present, and future
    • Steinman RM. Decisions about dendritic cells: past, present, and future. Annu Rev Immunol 2012; 30(1): 1-22
    • (2012) Annu Rev Immunol , vol.30 , Issue.1 , pp. 1-22
    • Steinman, R.M.1
  • 2
    • 84858780815 scopus 로고    scopus 로고
    • Cancer immunotherapy via dendritic cells
    • Palucka K, Banchereau J. Cancer immunotherapy via dendritic cells. Nat Rev Cancer 2012; 12(4): 265-277
    • (2012) Nat Rev Cancer , vol.12 , Issue.4 , pp. 265-277
    • Palucka, K.1    Banchereau, J.2
  • 3
    • 84966862666 scopus 로고    scopus 로고
    • Dendritic Cell-Based Immunotherapy: state of the Art and Beyond
    • Bol KF, Schreibelt G, Gerritsen WR et al. Dendritic Cell-Based Immunotherapy: state of the Art and Beyond. Clin Cancer Res 2016; 22(8): 1897-1906
    • (2016) Clin Cancer Res , vol.22 , Issue.8 , pp. 1897-1906
    • Bol, K.F.1    Schreibelt, G.2    Gerritsen, W.R.3
  • 4
    • 84928195112 scopus 로고    scopus 로고
    • Cancer immunotherapy A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
    • Carreno BM, Magrini V, Becker-Hapak M et al. Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells. Science 2015; 348(6236): 803-808
    • (2015) Science , vol.348 , Issue.6236 , pp. 803-808
    • Carreno, B.M.1    Magrini, V.2    Becker-Hapak, M.3
  • 5
    • 84884721824 scopus 로고    scopus 로고
    • A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients
    • Wilgenhof S, Van Nuffel AM, Benteyn D et al. A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients. Ann Oncol 2013; 24(10): 2686-2693
    • (2013) Ann Oncol , vol.24 , Issue.10 , pp. 2686-2693
    • Wilgenhof, S.1    Van Nuffel, A.M.2    Benteyn, D.3
  • 6
    • 84883466843 scopus 로고    scopus 로고
    • A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside
    • Chiang CL, Kandalaft LE, Tanyi J et al. A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside. Clin Cancer Res 2013; 19(17): 4801-4815
    • (2013) Clin Cancer Res , vol.19 , Issue.17 , pp. 4801-4815
    • Chiang, C.L.1    Kandalaft, L.E.2    Tanyi, J.3
  • 7
    • 84873989551 scopus 로고    scopus 로고
    • Comparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients
    • Prins RM, Wang X, Soto H et al. Comparison of glioma-associated antigen peptide-loaded versus autologous tumor lysate-loaded dendritic cell vaccination in malignant glioma patients. J Immunother 2013; 36(2): 152-157
    • (2013) J Immunother , vol.36 , Issue.2 , pp. 152-157
    • Prins, R.M.1    Wang, X.2    Soto, H.3
  • 8
    • 84898733422 scopus 로고    scopus 로고
    • Intratumoral immunization: a new paradigm for cancer therapy
    • Marabelle A, Kohrt H, Caux C, Levy R. Intratumoral immunization: a new paradigm for cancer therapy. Clin Cancer Res 2014; 20(7): 1747-1756
    • (2014) Clin Cancer Res , vol.20 , Issue.7 , pp. 1747-1756
    • Marabelle, A.1    Kohrt, H.2    Caux, C.3    Levy, R.4
  • 9
    • 85007010443 scopus 로고    scopus 로고
    • Intratumoral delivery of immunotherapy-act locally, think globally
    • Aznar MA, Tinari N, Rullan AJ et al. Intratumoral delivery of immunotherapy-act locally, think globally. J Immunol 2017; 198(1): 31-39
    • (2017) J Immunol , vol.198 , Issue.1 , pp. 31-39
    • Aznar, M.A.1    Tinari, N.2    Rullan, A.J.3
  • 10
    • 84976286494 scopus 로고    scopus 로고
    • Modulation of innate immunity in the tumor microenvironment
    • Gonzalez-Gugel E, Saxena M, Bhardwaj N. Modulation of innate immunity in the tumor microenvironment. Cancer Immunol Immunother 2016; 65(10): 1261-1268
    • (2016) Cancer Immunol Immunother , vol.65 , Issue.10 , pp. 1261-1268
    • Gonzalez-Gugel, E.1    Saxena, M.2    Bhardwaj, N.3
  • 11
    • 84962747427 scopus 로고    scopus 로고
    • Designing therapeutic cancer vaccines by mimicking viral infections
    • Sultan H, Fesenkova VI, Addis D et al. Designing therapeutic cancer vaccines by mimicking viral infections. Cancer Immunol Immunother 2017; 66(2): 203-213
    • (2017) Cancer Immunol Immunother , vol.66 , Issue.2 , pp. 203-213
    • Sultan, H.1    Fesenkova, V.I.2    Addis, D.3
  • 12
    • 56549116047 scopus 로고    scopus 로고
    • Toll-like receptor and RIG-I-like receptor signaling
    • Kawai T, Akira S. Toll-like receptor and RIG-I-like receptor signaling. Ann N Y Acad Sci 2008; 1143: 1-20
    • (2008) Ann N Y Acad Sci , vol.1143 , pp. 1-20
    • Kawai, T.1    Akira, S.2
  • 13
    • 84923102478 scopus 로고    scopus 로고
    • Vaccine adjuvant uses of poly-IC and derivatives
    • Martins KA, Bavari S, Salazar AM. Vaccine adjuvant uses of poly-IC and derivatives. Expert Rev Vaccines 2015; 14(3): 447-459
    • (2015) Expert Rev Vaccines , vol.14 , Issue.3 , pp. 447-459
    • Martins, K.A.1    Bavari, S.2    Salazar, A.M.3
  • 14
    • 0016777909 scopus 로고
    • A modified polyriboinosinicpolyribocytidylic acid complex that induces interferon in primates
    • Levy HB, Baer G, Baron S et al. A modified polyriboinosinicpolyribocytidylic acid complex that induces interferon in primates. J Infect Dis 1975; 132(4): 434-439
    • (1975) J Infect Dis , vol.132 , Issue.4 , pp. 434-439
    • Levy, H.B.1    Baer, G.2    Baron, S.3
  • 15
    • 0021950864 scopus 로고
    • Immunotherapeutic potential in murine tumor models of polyinosinic-polycytidylic acid and poly-Llysine solubilized by carboxymethylcellulose
    • Talmadge JE, Adams J, Phillips H et al. Immunotherapeutic potential in murine tumor models of polyinosinic-polycytidylic acid and poly-Llysine solubilized by carboxymethylcellulose. Cancer Res 1985; 45: 1066-1072
    • (1985) Cancer Res , vol.45 , pp. 1066-1072
    • Talmadge, J.E.1    Adams, J.2    Phillips, H.3
  • 16
    • 84954053287 scopus 로고    scopus 로고
    • Cancer immunotherapy with immunomodulatory anti-CD137 and anti-PD-1 monoclonal antibodies requires BATF3-dependent dendritic cells
    • Sanchez-Paulete AR, Cueto FJ, Martinez-LopezMet al. Cancer immunotherapy with immunomodulatory anti-CD137 and anti-PD-1 monoclonal antibodies requires BATF3-dependent dendritic cells. Cancer Discov 2016; 6(1): 71-79
    • (2016) Cancer Discov , vol.6 , Issue.1 , pp. 71-79
    • Sanchez-Paulete, A.R.1    Cueto, F.J.2    Martinez-Lopez, M.3
  • 17
    • 84855486511 scopus 로고    scopus 로고
    • Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans
    • Caskey M, Lefebvre F, Filali-Mouhim A et al. Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans. J Exp Med 2011; 208(12): 2357-2366
    • (2011) J Exp Med , vol.208 , Issue.12 , pp. 2357-2366
    • Caskey, M.1    Lefebvre, F.2    Filali-Mouhim, A.3
  • 18
    • 84923089650 scopus 로고    scopus 로고
    • Therapeutic in situ autovaccination against solid cancers with intratumoral poly-ICLC: case report, hypothesis, and clinical trial
    • Salazar AM, Erlich RB, Mark A et al. Therapeutic in situ autovaccination against solid cancers with intratumoral poly-ICLC: case report, hypothesis, and clinical trial. Cancer Immunol Res 2014; 2(8): 720-724
    • (2014) Cancer Immunol Res , vol.2 , Issue.8 , pp. 720-724
    • Salazar, A.M.1    Erlich, R.B.2    Mark, A.3
  • 19
    • 85040443512 scopus 로고    scopus 로고
    • A Phase I trial using local regional treatment, nonlethal irradiation, intratumoral and systemic polyinosinic-polycytidylic acid polylysine carboxymethylcellulose to treat liver cancer: in search of the abscopal effect
    • de la Torre AN, Contractor S, Castaneda I et al. A Phase I trial using local regional treatment, nonlethal irradiation, intratumoral and systemic polyinosinic-polycytidylic acid polylysine carboxymethylcellulose to treat liver cancer: in search of the abscopal effect. J Hepatocell Carcinoma 2017; 4: 111-121
    • (2017) J Hepatocell Carcinoma , vol.4 , pp. 111-121
    • de la Torre, A.N.1    Contractor, S.2    Castaneda, I.3
  • 20
    • 79951978155 scopus 로고    scopus 로고
    • Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with (alpha)-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma
    • Okada H, Kalinski P, Ueda R et al. Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with (alpha)-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma. J Clin Oncol 2011; 29(3): 330-336
    • (2011) J Clin Oncol , vol.29 , Issue.3 , pp. 330-336
    • Okada, H.1    Kalinski, P.2    Ueda, R.3
  • 21
    • 82755189230 scopus 로고    scopus 로고
    • Pilot clinical trial of type 1 dendritic cells loaded with autologous tumor lysates combined with GM-CSF, pegylated IFN, and cyclophosphamide for metastatic cancer patients
    • Alfaro C, Perez-Gracia JL, Suarez N et al. Pilot clinical trial of type 1 dendritic cells loaded with autologous tumor lysates combined with GM-CSF, pegylated IFN, and cyclophosphamide for metastatic cancer patients. J Immunol 2011; 187(11): 6130-6142
    • (2011) J Immunol , vol.187 , Issue.11 , pp. 6130-6142
    • Alfaro, C.1    Perez-Gracia, J.L.2    Suarez, N.3
  • 22
    • 85019054219 scopus 로고    scopus 로고
    • A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescenceguided surgery in newly diagnosed glioblastoma patients
    • Inoges S, Tejada S, de Cerio AL et al. A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescenceguided surgery in newly diagnosed glioblastoma patients. J Transl Med 2017; 15(1): 104
    • (2017) J Transl Med , vol.15 , Issue.1 , pp. 104
    • Inoges, S.1    Tejada, S.2    de Cerio, A.L.3
  • 23
    • 79952711945 scopus 로고    scopus 로고
    • Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy
    • Prins RM, Soto H, Konkankit V et al. Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy. Clin Cancer Res 2011; 17(6): 1603-1615
    • (2011) Clin Cancer Res , vol.17 , Issue.6 , pp. 1603-1615
    • Prins, R.M.1    Soto, H.2    Konkankit, V.3
  • 24
    • 84937846973 scopus 로고    scopus 로고
    • Evolving synergistic combinations of targeted immunotherapies to combat cancer
    • Melero I, Berman DM, Aznar MA et al. Evolving synergistic combinations of targeted immunotherapies to combat cancer. Nat Rev Cancer 2015; 15: 457-472
    • (2015) Nat Rev Cancer , vol.15 , pp. 457-472
    • Melero, I.1    Berman, D.M.2    Aznar, M.A.3
  • 25
    • 85028829596 scopus 로고    scopus 로고
    • Oncolytic virotherapy promotes intratumoral T cell infiltration and improves anti-PD-1 immunotherapy
    • Ribas A, Dummer R, Puzanov I et al. Oncolytic virotherapy promotes intratumoral T cell infiltration and improves anti-PD-1 immunotherapy. Cell 2017; 170(6): 1109-1119. e1110
    • (2017) Cell , vol.170 , Issue.6
    • Ribas, A.1    Dummer, R.2    Puzanov, I.3
  • 26
    • 85018813817 scopus 로고    scopus 로고
    • Integrative development of a TLR8 agonist for ovarian cancer chemoimmunotherapy
    • Monk BJ, Facciabene A, Brady WE et al. Integrative development of a TLR8 agonist for ovarian cancer chemoimmunotherapy. Clin Cancer Res 2017; 23(8): 1955-1966
    • (2017) Clin Cancer Res , vol.23 , Issue.8 , pp. 1955-1966
    • Monk, B.J.1    Facciabene, A.2    Brady, W.E.3
  • 27
    • 85019984969 scopus 로고    scopus 로고
    • A phase 2, randomized, doubleblind, placebo-controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study
    • Monk BJ, Brady MF, Aghajanian C et al. A phase 2, randomized, doubleblind, placebo-controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study. Ann Oncol 2017; 28(5): 996-1004
    • (2017) Ann Oncol , vol.28 , Issue.5 , pp. 996-1004
    • Monk, B.J.1    Brady, M.F.2    Aghajanian, C.3
  • 28
    • 78049420571 scopus 로고    scopus 로고
    • In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study
    • Brody JD, Ai WZ, Czerwinski DK et al. In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study. J Clin Oncol 2010; 28(28): 4324-4332
    • (2010) J Clin Oncol , vol.28 , Issue.28 , pp. 4324-4332
    • Brody, J.D.1    Ai, W.Z.2    Czerwinski, D.K.3
  • 29
    • 84991790808 scopus 로고    scopus 로고
    • Abscopal effects of radiotherapy are enhanced by combined immunostimulatory mAbs and are dependent on CD8 T cells and crosspriming
    • Rodriguez-Ruiz ME, Rodriguez I, Garasa S et al. Abscopal effects of radiotherapy are enhanced by combined immunostimulatory mAbs and are dependent on CD8 T cells and crosspriming. Cancer Res 2016; 76(20): 5994-6005
    • (2016) Cancer Res , vol.76 , Issue.20 , pp. 5994-6005
    • Rodriguez-Ruiz, M.E.1    Rodriguez, I.2    Garasa, S.3
  • 30
    • 69949085196 scopus 로고    scopus 로고
    • Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody
    • Dewan MZ, Galloway AE, Kawashima N et al. Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody. Clin Cancer Res 2009; 15(17): 5379-5388
    • (2009) Clin Cancer Res , vol.15 , Issue.17 , pp. 5379-5388
    • Dewan, M.Z.1    Galloway, A.E.2    Kawashima, N.3
  • 31
    • 84937525789 scopus 로고    scopus 로고
    • Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial
    • Golden EB, Chhabra A, Chachoua A et al. Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial. Lancet Oncol 2015; 16: 795-803
    • (2015) Lancet Oncol , vol.16 , pp. 795-803
    • Golden, E.B.1    Chhabra, A.2    Chachoua, A.3
  • 32
    • 85003053854 scopus 로고    scopus 로고
    • An abscopal response to radiation and ipilimumab in a patient with metastatic non-small cell lung cancer
    • Golden EB, Demaria S, Schiff PB et al. An abscopal response to radiation and ipilimumab in a patient with metastatic non-small cell lung cancer. Cancer Immunol Res 2013; 1(6): 365-372
    • (2013) Cancer Immunol Res , vol.1 , Issue.6 , pp. 365-372
    • Golden, E.B.1    Demaria, S.2    Schiff, P.B.3
  • 33
    • 84974803082 scopus 로고    scopus 로고
    • Radiotherapy: changing the Game in Immunotherapy
    • Demaria S, Coleman CN, Formenti SC. Radiotherapy: changing the Game in Immunotherapy. Trends Cancer 2016; 2(6): 286-294
    • (2016) Trends Cancer , vol.2 , Issue.6 , pp. 286-294
    • Demaria, S.1    Coleman, C.N.2    Formenti, S.C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.